"If government can't stop the smokes, no way we can stop selling them": why retailers want Government to act.

08:00 EDT 21st September 2018 | BioPortfolio

Summary of ""If government can't stop the smokes, no way we can stop selling them": why retailers want Government to act."

No Summary Available


Journal Details

This article was published in the following journal.

Name: The New Zealand medical journal
ISSN: 1175-8716
Pages: 89-91


DeepDyve research library

PubMed Articles [935 Associated PubMed Articles listed on BioPortfolio]

How important to dairies is selling tobacco? Views of dairy owners and managers on tobacco retailing.

Given the Government's commitment to reducing tobacco availability to minimal levels by 2025, finding ways to decrease the number of tobacco retailers is an important task. We assessed the perceived i...

To stop or not to stop: a value of information view.

Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay.

Calibrated automated thrombography (CAT) is useful in monitoring the anticoagulant status of patients treated with direct oral anticoagulants (DOACs). This as well as other applications of the CAT are...

Perceived addiction to smoking and associations with motivation to stop, quit attempts and quitting success: A prospective study of English smokers.

Some argue that perceived addiction to smoking (PAS) might undermine motivation to stop. We examined the association of PAS with motivation to stop in a population sample and assessed its association ...

Outcomes of Healthy Eating Ad Campaigns: A Systematic Review.

Social marketing campaigns seeking to promote healthy eating hold promise in precision messaging and behavior change related to a key component of healthy living medicine. A systematic review that exa...

Clinical Trials [5762 Associated Clinical Trials listed on BioPortfolio]

Evaluation of One-stop Strategy of EVAR and PCI

The study is designed to evaluate the safety and effectiveness of the "one-stop" endovascular intervention strategy for patients with concomitant coronary artery disease and aortic atheros...

Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use

RATIONALE: A counseling program that motivates patients to stop smoking and drinking may reduce the risk of oral cancer. It is not yet known whether motivational stop smoking counseling or...

Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment

This study will enroll CML patients who have failed a first TKI stopping attempt. After failure and at least a year of TKI treatment, patients will proceed to dasatinib treatment for anoth...

Computer-Based Stop Smoking Program in Assisting Doctors in Helping Adults Stop Smoking

RATIONALE: Computer-based stop smoking programs may assist doctors in helping patients stop smoking. PURPOSE: This randomized clinical trial is studying how well a computer-based stop smo...

Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients

The aim of this study was to compare the ability of clinical scores (P-SAP, OSA50, DES-OSA, STOP-Bang with former algorithm, and STOP-Bang with new algorithm).

Medical and Biotech [MESH] Definitions

An mRNA metabolic process that distinguishes a normal STOP CODON from a premature stop codon (NONSENSE CODON) and facilitates rapid degradation of aberrant mRNAs containing premature stop codons.

An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon.

An APOBEC deaminase catalytic subunit of the apolipoprotein B (APOB) MESSENGER RNA (mRNA) editing enzyme complex that is involved in post-transcriptional editing of a CAA codon for GLYCINE to a UAA STOP CODON in the ApoB mRNA. It also functions in CGA (ARGININE) to UGA STOP CODON editing of NEUROFIBROMIN 1 mRNA and EPIGENETIC PROCESSES.

Processes occurring in various organisms by which new genes arise, i.e. the duplication of a single gene. In contiguous gene duplication, the duplicated sequence coexists within the boundaries set by the start and stop signals for protein synthesis of the original, resulting in a larger transcription product and protein at the expense of the preexisting protein. In discrete gene duplication, the duplicated sequence is outside the start and stop signals, resulting in two independent genes (GENES, DUPLICATE) and gene products. Gene duplication may result in a MULTIGENE FAMILY; supergenes or PSEUDOGENES. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)

A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate).

Quick Search

DeepDyve research library

Searches Linking to this Article